MetaCap

Windward Bio Group AG (WWB)

NASDAQ: WWBHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

24.29+0.275 (+1.15%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

WWB stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
-$1.18
52-week range
18.35 – 33.99
Day range
22.47 – 26.20
Volume / Avg
158.59K / 434.33K
Beta
—

52-week range

$18.35$33.99

WWB stock today

On Nov 20, WWB ended the session at $24.29, adding $0.275 (1.15%), versus the S&P 500's 3.70% decline. Trading was light, with 158.59K shares changing hands, about 37% of the average daily volume. At this level, WWB sits in the middle of its 52-week range of $18.35 to $33.99: 28.6% below the high, set on Nov 13, 2026 and 32.3% above the low.

Windward Bio Group has posted a net loss over the last twelve months (EPS of -$1.18), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Windward Bio Group

Company profile

Windward Bio Group AG operates as a clinical stage biotechnology company that develops ultra-long-acting antibody medicines for patients with respiratory and dermatologic diseases. Its drug candidates WIN378, an ultra-long-acting and novel fully human monoclonal antibody, which has completed Phase I clinical study that inhibits thymic stromal lymphopoietin (TSLP); and WIN027, an ultra-long-acting bispecific antibody that is in Phase I clinical study simultaneously targets TSLP and interleukin-13 (IL-13) and two clinically validated drivers of inflammatory disease. The company has collaboration agreements with Sichuan Kelun-Biotech BioPharmaceutical Co., Ltd, Harbour BioMed (Shanghai) Co., Ltd, and Qyuns Therapeutics Co., Ltd.

Industry
Biotechnology: Biological Products (No Diagnostic Substances)
CEO
Dr. Luca Santarelli M.D.
Headquarters
Basel
Employees
33
IPO year
2026

WWB news

All WWB news

Windward Bio Group peers

Health Care sector
WWB peer companies
CompanyPrice% ChgMarket capCompare
MESOMesoblast Limited ADR10.89-2.59%$1.41Bvs WWB
ALVOAlvotech4.12-3.96%$1.47Bvs WWB
IMCRImmunocore Holdings plc ADR26.41-0.83%$1.36Bvs WWB
RXRXRecursion Pharmaceuticals Inc. Class A2.45-9.93%$1.53Bvs WWB
VIRVir Biotechnology Inc.8.39-5.41%$1.56Bvs WWB
NVAXNovavax Inc.7.47-3.24%$1.23Bvs WWB
TSHATaysha Gene Therapies Inc.3.72-1.33%$1.21Bvs WWB
VORVor Biopharma Inc.19.19+3.62%$1.18Bvs WWB

Indexes, lists and sector

Windward Bio Group stock FAQ

What is Windward Bio Group's stock price today?

WWB last traded at $24.29 as of Nov 20, 4:00 PM EST, up 1.15% on the day. Prices are delayed at least 15 minutes.

Who is Windward Bio Group's CEO?

Dr. Luca Santarelli M.D. is the chief executive officer of Windward Bio Group AG, which has about 33 employees.

What is the WWB 52-week high?

The 52-week high for WWB is $33.99 and the 52-week low is $18.35. The stock is currently 28.6% below its high.

Compare WWB